• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

c-Src激酶的高特异性双底物抑制剂。

Exquisitely specific bisubstrate inhibitors of c-Src kinase.

作者信息

Brandvold Kristoffer R, Santos Shana M, Breen Meghan E, Lachacz Eric J, Steffey Michael E, Soellner Matthew B

机构信息

†Department of Medicinal Chemistry and ‡Department of Chemistry, University of Michigan, 930 N. University Avenue, Ann Arbor, Michigan 48109, United States.

出版信息

ACS Chem Biol. 2015 Jun 19;10(6):1387-91. doi: 10.1021/cb501048b. Epub 2015 Mar 31.

DOI:10.1021/cb501048b
PMID:25793938
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4578647/
Abstract

We have developed a modular approach to bisubstrate inhibition of protein kinases. We apply our methodology to c-Src and identify a highly selective bisubstrate inhibitor for this target. Our approach has yielded the most selective c-Src inhibitor to date, and the methodology to render the bisubstrate inhibitor cell-permeable provides a highly valuable tool for the study of c-Src signaling. In addition, we have applied our bisubstrate inhibitor to develop a novel screening methodology to identify non-ATP-competitive inhibitors of c-Src. Using this methodology, we have discovered the most potent non-ATP-competitive inhibitor reported to date. Our methodology is designed to be general and could be applicable to additional kinases inhibited by the promiscuous ATP-competitive fragment used in our studies.

摘要

我们已经开发出一种用于双底物抑制蛋白激酶的模块化方法。我们将该方法应用于c-Src,并鉴定出针对此靶点的一种高选择性双底物抑制剂。我们的方法产生了迄今为止最具选择性的c-Src抑制剂,并且使双底物抑制剂具有细胞渗透性的方法为研究c-Src信号传导提供了一个非常有价值的工具。此外,我们已将我们的双底物抑制剂应用于开发一种新型筛选方法,以鉴定c-Src的非ATP竞争性抑制剂。使用这种方法,我们发现了迄今为止报道的最有效的非ATP竞争性抑制剂。我们的方法设计得具有通用性,可能适用于受我们研究中使用的混杂ATP竞争性片段抑制的其他激酶。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed8e/4578647/3cd311986602/nihms-723069-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed8e/4578647/281ec0289831/nihms-723069-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed8e/4578647/257bdbb9cec6/nihms-723069-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed8e/4578647/107e58633233/nihms-723069-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed8e/4578647/32cc11751a67/nihms-723069-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed8e/4578647/3cd311986602/nihms-723069-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed8e/4578647/281ec0289831/nihms-723069-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed8e/4578647/257bdbb9cec6/nihms-723069-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed8e/4578647/107e58633233/nihms-723069-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed8e/4578647/32cc11751a67/nihms-723069-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed8e/4578647/3cd311986602/nihms-723069-f0005.jpg

相似文献

1
Exquisitely specific bisubstrate inhibitors of c-Src kinase.c-Src激酶的高特异性双底物抑制剂。
ACS Chem Biol. 2015 Jun 19;10(6):1387-91. doi: 10.1021/cb501048b. Epub 2015 Mar 31.
2
Bivalent Inhibitors of c-Src Tyrosine Kinase That Bind a Regulatory Domain.结合调节结构域的c-Src酪氨酸激酶双价抑制剂
Bioconjug Chem. 2016 Jul 20;27(7):1745-9. doi: 10.1021/acs.bioconjchem.6b00243. Epub 2016 Jun 22.
3
Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.一类新型强效选择性三取代嘌呤类化合物抑制Src酪氨酸激酶的结构基础
Chem Biol Drug Des. 2006 Jan;67(1):46-57. doi: 10.1111/j.1747-0285.2005.00316.x.
4
Substrate activity screening with kinases: discovery of small-molecule substrate-competitive c-Src inhibitors.激酶底物活性筛选:发现小分子底物竞争性c-Src抑制剂。
Angew Chem Int Ed Engl. 2014 Jul 1;53(27):7010-3. doi: 10.1002/anie.201311096. Epub 2014 May 2.
5
PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.PH006 是一种新型、选择性Src 激酶抑制剂,能在体内外抑制人乳腺癌的生长和转移。
Breast Cancer Res Treat. 2011 Nov;130(1):85-96. doi: 10.1007/s10549-010-1302-4. Epub 2010 Dec 22.
6
Allosteric Modulation of Src Family Kinases with ATP-Competitive Inhibitors.ATP竞争性抑制剂对Src家族激酶的变构调节
Methods Mol Biol. 2017;1636:79-89. doi: 10.1007/978-1-4939-7154-1_6.
7
Naturally occurring homoisoflavonoids function as potent protein tyrosine kinase inhibitors by c-Src-based high-throughput screening.通过基于c-Src的高通量筛选,天然存在的高异黄酮类化合物可作为有效的蛋白酪氨酸激酶抑制剂。
J Med Chem. 2008 Aug 14;51(15):4419-29. doi: 10.1021/jm701501x. Epub 2008 Jul 9.
8
Highly specific, bisubstrate-competitive Src inhibitors from DNA-templated macrocycles.基于 DNA 模板的大环化合物的高特异性、双底物竞争性Src 抑制剂。
Nat Chem Biol. 2012 Feb 19;8(4):366-74. doi: 10.1038/nchembio.792.
9
Irreversible inhibitors of c-Src kinase that target a nonconserved cysteine.靶向非保守半胱氨酸的 c-Src 激酶不可逆抑制剂。
ACS Chem Biol. 2012 Nov 16;7(11):1910-7. doi: 10.1021/cb300337u. Epub 2012 Sep 5.
10
Development of selective bisubstrate-based inhibitors against protein kinase C (PKC) isozymes by using dynamic peptide microarrays.利用动态肽微阵列开发针对蛋白激酶C(PKC)同工酶的选择性双底物抑制剂。
Chembiochem. 2009 Aug 17;10(12):2042-51. doi: 10.1002/cbic.200900199.

引用本文的文献

1
The Src family kinase inhibitor drug Dasatinib and glucocorticoids display synergistic activity against tongue squamous cell carcinoma and reduce MET kinase activity.Src家族激酶抑制剂药物达沙替尼与糖皮质激素对舌鳞状细胞癌具有协同活性,并降低MET激酶活性。
Cell Commun Signal. 2025 Jun 19;23(1):293. doi: 10.1186/s12964-025-02129-8.
2
Bisubstrate Analog Inhibitors of DXP Synthase Show Species Specificity.1-脱氧-D-木酮糖-5-磷酸合酶的双底物类似物抑制剂具有物种特异性。
Biochemistry. 2025 Jan 21;64(2):432-447. doi: 10.1021/acs.biochem.4c00549. Epub 2025 Jan 7.
3
The prospect of substrate-based kinase inhibitors to improve target selectivity and overcome drug resistance.

本文引用的文献

1
Small molecule substrate phosphorylation site inhibitors of protein kinases: approaches and challenges.蛋白激酶的小分子底物磷酸化位点抑制剂:方法与挑战
ACS Chem Biol. 2015 Jan 16;10(1):175-89. doi: 10.1021/cb5008376. Epub 2014 Dec 23.
2
Substrate activity screening with kinases: discovery of small-molecule substrate-competitive c-Src inhibitors.激酶底物活性筛选:发现小分子底物竞争性c-Src抑制剂。
Angew Chem Int Ed Engl. 2014 Jul 1;53(27):7010-3. doi: 10.1002/anie.201311096. Epub 2014 May 2.
3
Bivalent inhibitors of protein kinases.
基于底物的激酶抑制剂改善靶点选择性和克服耐药性的前景。
Chem Sci. 2024 Jul 13;15(33):13130-13147. doi: 10.1039/d4sc01088d. eCollection 2024 Aug 22.
4
Probing the Plasticity in the Active Site of Protein N-terminal Methyltransferase 1 Using Bisubstrate Analogues.利用双底物类似物探究蛋白质N-末端甲基转移酶1活性位点的可塑性
J Med Chem. 2020 Aug 13;63(15):8419-8431. doi: 10.1021/acs.jmedchem.0c00770. Epub 2020 Jul 16.
5
Targeting Dynamic ATP-Binding Site Features Allows Discrimination between Highly Homologous Protein Kinases.靶向动态 ATP 结合位点可区分高度同源的蛋白激酶。
ACS Chem Biol. 2019 Jun 21;14(6):1249-1259. doi: 10.1021/acschembio.9b00214. Epub 2019 May 13.
6
Structural and Biochemical Basis for Intracellular Kinase Inhibition by Src-specific Peptidic Macrocycles.Src 特异性肽类大环化合物抑制细胞内激酶的结构和生化基础。
Cell Chem Biol. 2016 Sep 22;23(9):1103-1112. doi: 10.1016/j.chembiol.2016.07.017. Epub 2016 Sep 1.
7
Bivalent Inhibitors of c-Src Tyrosine Kinase That Bind a Regulatory Domain.结合调节结构域的c-Src酪氨酸激酶双价抑制剂
Bioconjug Chem. 2016 Jul 20;27(7):1745-9. doi: 10.1021/acs.bioconjchem.6b00243. Epub 2016 Jun 22.
8
Rapid Discovery and Structure-Activity Relationships of Pyrazolopyrimidines That Potently Suppress Breast Cancer Cell Growth via SRC Kinase Inhibition with Exceptional Selectivity over ABL Kinase.通过抑制SRC激酶有效抑制乳腺癌细胞生长且对ABL激酶具有极高选择性的吡唑并嘧啶的快速发现及构效关系
J Med Chem. 2016 May 26;59(10):4697-710. doi: 10.1021/acs.jmedchem.6b00065. Epub 2016 May 4.
9
Conversion of a Single Polypharmacological Agent into Selective Bivalent Inhibitors of Intracellular Kinase Activity.将单一多靶点药物转化为细胞内激酶活性的选择性双价抑制剂
ACS Chem Biol. 2016 Jan 15;11(1):121-31. doi: 10.1021/acschembio.5b00847. Epub 2015 Nov 6.
10
Temporal Changes in Caspase-1 and Caspase-8 Activities Following Brain Hypoxia With and Without Src kinase Inhibition in a Piglet Animal Model.仔猪动物模型中脑缺氧伴或不伴Src激酶抑制后Caspase-1和Caspase-8活性的时间变化
Neurochem Res. 2015 Nov;40(11):2270-9. doi: 10.1007/s11064-015-1717-8. Epub 2015 Sep 5.
双价蛋白激酶抑制剂。
Crit Rev Biochem Mol Biol. 2014 Mar-Apr;49(2):102-15. doi: 10.3109/10409238.2013.875513. Epub 2014 Feb 25.
4
Development of a highly selective c-Src kinase inhibitor.开发一种高选择性的 c-Src 激酶抑制剂。
ACS Chem Biol. 2012 Aug 17;7(8):1393-8. doi: 10.1021/cb300172e. Epub 2012 Jun 4.
5
Testing the promiscuity of commercial kinase inhibitors against the AGC kinase group using a split-luciferase screen.利用荧光素酶报告基因筛选检测商业激酶抑制剂对 AGC 激酶组的非选择性抑制作用。
J Med Chem. 2012 Feb 23;55(4):1526-37. doi: 10.1021/jm201265f. Epub 2012 Feb 10.
6
Tinkering outside the kinase ATP box: allosteric (type IV) and bivalent (type V) inhibitors of protein kinases.激酶 ATP 盒外的修补:蛋白激酶的变构(IV 型)和双价(V 型)抑制剂。
Future Med Chem. 2011 Jan;3(1):29-43. doi: 10.4155/fmc.10.272.
7
A coiled-coil enabled split-luciferase three-hybrid system: applied toward profiling inhibitors of protein kinases.一种卷曲螺旋结构域介导的分割荧光素酶三杂交系统:应用于蛋白激酶抑制剂的谱分析。
J Am Chem Soc. 2010 Aug 25;132(33):11727-35. doi: 10.1021/ja104491h.
8
Probing the probes: fitness factors for small molecule tools.探索探针:小分子工具的适用性因素
Chem Biol. 2010 Jun 25;17(6):561-77. doi: 10.1016/j.chembiol.2010.05.013.
9
Bisubstrate inhibitors of protein kinases: from principle to practical applications.双底物蛋白激酶抑制剂:从原理到实际应用。
ChemMedChem. 2010 Jan;5(1):23-34. doi: 10.1002/cmdc.200900252.
10
Development and applications of a broad-coverage, TR-FRET-based kinase binding assay platform.一种基于时间分辨荧光共振能量转移(TR-FRET)的广泛覆盖激酶结合分析平台的开发与应用
J Biomol Screen. 2009 Sep;14(8):924-35. doi: 10.1177/1087057109339207. Epub 2009 Jun 29.